X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6522) 6522
Publication (391) 391
Book Chapter (48) 48
Book Review (36) 36
Magazine Article (11) 11
Newsletter (10) 10
Conference Proceeding (9) 9
Dissertation (8) 8
Web Resource (6) 6
Book / eBook (1) 1
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5110) 5110
male (2885) 2885
female (2810) 2810
rhabdomyosarcoma (2625) 2625
child (2433) 2433
oncology (2036) 2036
child, preschool (1792) 1792
adolescent (1727) 1727
index medicus (1710) 1710
rhabdomyosarcoma - pathology (1431) 1431
rhabdomyosarcoma - therapy (1324) 1324
infant (1259) 1259
rhabdomyosarcoma - drug therapy (1225) 1225
adult (1221) 1221
pediatrics (1093) 1093
combined modality therapy (1032) 1032
cancer (993) 993
children (950) 950
chemotherapy (939) 939
animals (925) 925
prognosis (825) 825
rhabdomyosarcoma - radiotherapy (810) 810
tumors (794) 794
surgery (760) 760
antineoplastic combined chemotherapy protocols - therapeutic use (749) 749
sarcoma (728) 728
intergroup rhabdomyosarcoma (659) 659
rhabdomyosarcoma - surgery (654) 654
radiotherapy (636) 636
rhabdomyosarcoma - diagnosis (622) 622
middle aged (576) 576
treatment outcome (567) 567
mice (500) 500
retrospective studies (462) 462
pathology (414) 414
rhabdomyosarcoma - mortality (411) 411
follow-up studies (410) 410
hematology (406) 406
neoplasm staging (405) 405
alveolar rhabdomyosarcoma (399) 399
aged (397) 397
childhood (378) 378
care and treatment (377) 377
therapy (377) 377
diagnosis (371) 371
cell line, tumor (365) 365
embryonal rhabdomyosarcoma (351) 351
radiology, nuclear medicine & medical imaging (344) 344
diagnosis, differential (341) 341
immunohistochemistry (328) 328
metastasis (328) 328
survival rate (320) 320
rats (318) 318
research (308) 308
antineoplastic agents - therapeutic use (307) 307
radiotherapy dosage (306) 306
neoplasm metastasis (305) 305
time factors (305) 305
expression (302) 302
health aspects (290) 290
tomography, x-ray computed (276) 276
rhabdomyosarcoma - metabolism (269) 269
infant, newborn (267) 267
rhabdomyosarcoma, embryonal - pathology (265) 265
rhabdomyosarcoma - genetics (264) 264
young adult (256) 256
sarcoma - pathology (254) 254
disease-free survival (252) 252
radiation therapy (245) 245
vincristine - administration & dosage (245) 245
magnetic resonance imaging (243) 243
sarcoma - therapy (242) 242
apoptosis (241) 241
soft-tissue sarcoma (236) 236
biopsy (227) 227
sarcoma - drug therapy (227) 227
analysis (226) 226
soft tissue neoplasms - pathology (225) 225
survival (225) 225
article (220) 220
cell biology (206) 206
patients (206) 206
cyclophosphamide - administration & dosage (202) 202
medicine (202) 202
neoplasm recurrence, local (202) 202
gene expression (201) 201
risk factors (201) 201
chemotherapy, adjuvant (199) 199
neoplasms (199) 199
head (197) 197
medicine & public health (196) 196
radiation (195) 195
dactinomycin - administration & dosage (194) 194
neoplasm transplantation (194) 194
fatal outcome (189) 189
neuroblastoma (188) 188
survival analysis (188) 188
rhabdomyosarcoma - diagnostic imaging (186) 186
soft tissue neoplasms - therapy (186) 186
age factors (184) 184
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5871) 5871
French (184) 184
German (172) 172
Japanese (89) 89
Spanish (60) 60
Polish (58) 58
Russian (49) 49
Chinese (42) 42
Italian (23) 23
Dutch (6) 6
Croatian (5) 5
Swedish (4) 4
Turkish (4) 4
Danish (3) 3
Romanian (3) 3
Serbian (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Hungarian (2) 2
Korean (2) 2
Portuguese (2) 2
Afrikaans (1) 1
Arabic (1) 1
Czech (1) 1
Finnish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 04/2012, Volume 82, Issue 5, pp. 1764 - 1770
Purpose: To compare the dosimetric parameters of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) in patients with... 
Intensity-modulated radiotherapy | 3D-CRT | IMRT | Three-dimensional conformal radiotherapy | Rhabdomyosarcoma | Intermediate risk | TISSUE | CANCER | RADIATION-THERAPY | TRIAL | ONCOLOGY | NECK-RHABDOMYOSARCOMA | CARCINOMA | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Humans | Rhabdomyosarcoma - pathology | Male | Radiotherapy, Intensity-Modulated - adverse effects | Rhabdomyosarcoma - radiotherapy | Rhabdomyosarcoma, Alveolar - mortality | Treatment Failure | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma - mortality | Sarcoma - radiotherapy | Rhabdomyosarcoma, Embryonal - pathology | Radiotherapy, Intensity-Modulated - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Radiotherapy, Intensity-Modulated - methods | Rhabdomyosarcoma, Alveolar - radiotherapy | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Sarcoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epidemiologic Methods | Radiotherapy, Conformal - mortality | Radiotherapy, Conformal - adverse effects | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy, Conformal - methods | Nuclear radiation | Analysis | Radiation | Medical care | Universities and colleges | Radiotherapy | Methods | Quality management | Index Medicus | PATIENTS | NEOPLASMS | INTEGRAL DOSES | FAILURES | TOXICITY | COMPARATIVE EVALUATIONS | CHILDREN | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | CONTROL | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 635 - 642
Purpose To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Conformal radiotherapy | Late effects | Proton radiotherapy | Parameningeal rhabdomyosarcoma | Pediatric | NECK RHABDOMYOSARCOMA | HEAD | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | INTENSITY-MODULATED RADIOTHERAPY | NONMETASTATIC RHABDOMYOSARCOMA | SOFT-TISSUE | CHILDREN | CHILDHOOD-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Follow-Up Studies | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Radiotherapy - adverse effects | Organ Sparing Treatments - methods | Rhabdomyosarcoma - radiotherapy | Meningeal Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - mortality | Massachusetts | Female | Rhabdomyosarcoma - drug therapy | Child | Rhabdomyosarcoma - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - radiotherapy | Treatment Outcome | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Meningeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy | Medical colleges | Nuclear radiation | DIAGNOSIS | PATIENTS | NEOPLASMS | FAILURES | PHOTONS | TEETH | RADIATION DOSES | CARIES | HISTOLOGY | PROTONS | SINUSES | MEDICAL RECORDS | NOSE | RADIATION DOSE UNITS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIOTHERAPY | SIDE EFFECTS | COBALT | CONTROL
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2013, Volume 40, Issue 2, pp. 187 - 192
Abstract Purpose To report on clinical outcome and toxicity profile after combined treatment that included radiation therapy (RT) in patients with localized... 
Hematology, Oncology and Palliative Medicine | Surgery | Reirradiation | Radio-induced sarcoma | Radiation therapy | Sarcoma | Functional outcome | SALVAGE | SURGERY | SOFT-TISSUE SARCOMAS | INSTITUTION | RANDOMIZED-TRIAL | LOCAL RECURRENCE | ONCOLOGY | EXPERIENCE | RADIOTHERAPY | CARCINOMA | BRACHYTHERAPY | Breast Neoplasms - surgery | Neoplasms, Radiation-Induced - surgery | Humans | Middle Aged | Child, Preschool | Male | Leiomyosarcoma - radiotherapy | Pelvic Neoplasms - radiotherapy | Young Adult | Rhabdomyosarcoma - radiotherapy | Leiomyosarcoma - surgery | Pelvic Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Child | Sarcoma - radiotherapy | Neoplasms, Radiation-Induced - radiotherapy | Pelvic Neoplasms - surgery | Hemangiosarcoma - drug therapy | Head and Neck Neoplasms - drug therapy | Treatment Outcome | Combined Modality Therapy | Sarcoma - drug therapy | Breast Neoplasms - drug therapy | Neoplasms, Radiation-Induced - drug therapy | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Hemangiosarcoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - surgery | Adolescent | Hemangiosarcoma - radiotherapy | Leiomyosarcoma - drug therapy | Aged | Rhabdomyosarcoma - surgery | Head and Neck Neoplasms - surgery | Cohort Studies | Radiotherapy | Nuclear radiation
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1413 - 1419
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 130 - 140
Abstract Objectives Dose-finding trials are fundamental to develop novel drugs for children and adolescents with advanced cancer. It is crucial to maximise... 
Hematology, Oncology and Palliative Medicine | Innovative Therapies for Children with Cancer | Dose-finding trial | Prognostic factor | Phase I trial | Children | Adolescents | Survival | ONCOLOGY TRIALS | SCORE | VALIDATION | I CLINICAL-TRIALS | CONTEXT | PEDIATRIC PHASE-I | CENTER EXPERIENCE | ONCOLOGY | Osteosarcoma - drug therapy | Multivariate Analysis | Prognosis | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Infant | Male | Neuroblastoma - mortality | Sarcoma, Ewing - mortality | Medulloblastoma - mortality | Ependymoma - drug therapy | Employment | Ependymoma - mortality | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Schools | Osteosarcoma - mortality | Glioma - mortality | Neuroectodermal Tumors, Primitive - mortality | Europe | Proportional Hazards Models | Neoplasms - mortality | Therapies, Investigational | Survival Rate | Sarcoma - drug therapy | Neoplasms - drug therapy | Sarcoma, Ewing - drug therapy | Neuroblastoma - drug therapy | Adolescent | Medulloblastoma - drug therapy | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Clinical Trials, Phase I as Topic | Glioma - drug therapy | Care and treatment | Patient outcomes | Children's hospitals | Oncology, Experimental | Clinical trials | Research | Health aspects | Cancer
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 4048 - 4056
Socioeconomic factors affect the use of proton radiotherapy in children. Whether this disparity is related to differences in the referral patterns, the... 
radiotherapy | socioeconomic factors | protons | photons | malignancy | pediatrics | UNITED-STATES | MASTECTOMY | STAGE BREAST-CANCER | DISTANCE | EPENDYMOMA | RACIAL DISPARITIES | ONCOLOGY | PROSTATE-CANCER | PHOTON RADIOTHERAPY | DATA-BASE | CLINICAL-OUTCOMES | Radiotherapy - utilization | United States | Humans | Brain Neoplasms - pathology | Child, Preschool | Rhabdomyosarcoma - pathology | Infant | Male | Educational Status | Bone Neoplasms - pathology | Socioeconomic Factors | Insurance, Health - statistics & numerical data | Young Adult | Neoplasm Metastasis | Rhabdomyosarcoma - radiotherapy | Medulloblastoma - radiotherapy | Medulloblastoma - pathology | Ependymoma - pathology | Female | Neoplasms - radiotherapy | Cerebellar Neoplasms - pathology | Brain Neoplasms - radiotherapy | Medicaid | Odds Ratio | Child | Infant, Newborn | Proton Therapy - utilization | Income - statistics & numerical data | Medically Uninsured | Logistic Models | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Managed Care Programs | Travel | Bone Neoplasms - radiotherapy | Adolescent | Neoplasms - pathology | Cerebellar Neoplasms - radiotherapy | Ependymoma - radiotherapy | Usage | Children | Radiotherapy | Social economics | Health aspects | Analysis | Health care | Pediatrics | Populations | Socio-economic aspects | Radiation | Rhabdomyosarcoma | Economic factors | Social factors | Malignancy | Radiation therapy | Regression analysis | Tissues | Cancer therapies | Patients | Socioeconomics | Metastases | Confidence intervals | Government programs | Socioeconomic factors | Medulloblastoma | Background radiation | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 3, pp. e151 - e155
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 72, Issue 3, pp. 884 - 891
Purpose To report our initial experience using intensity-modulated radiotherapy (IMRT) with a cone-down boost for pediatric head-and-neck rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck | Cone-down boost | Intensity-modulated radiotherapy | IMRT | Pediatric | Rhabdomyosarcoma | CHILDHOOD RHABDOMYOSARCOMA | TISSUE | INTERGROUP-RHABDOMYOSARCOMA | cone-down boost | OROPHARYNGEAL CARCINOMA | TUMORS | pediatric | RADIATION-THERAPY IMRT | CHILDREN | intensity-modulated radiotherapy | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DISEASE | head and neck | EXPERIENCE | rhabdomyosarcoma | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Mouth Neoplasms - drug therapy | Humans | Child, Preschool | Male | Tomography, X-Ray Computed | Young Adult | Meningeal Neoplasms - drug therapy | Ear Neoplasms - radiotherapy | Female | Mouth Neoplasms - radiotherapy | Retrospective Studies | Child | Rhabdomyosarcoma, Alveolar - drug therapy | Ear Neoplasms - drug therapy | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - diagnostic imaging | Rhabdomyosarcoma, Alveolar - radiotherapy | Combined Modality Therapy | Head and Neck Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Mouth Neoplasms - diagnostic imaging | Ear Neoplasms - diagnostic imaging | Meningeal Neoplasms - diagnostic imaging | Eye Neoplasms - radiotherapy | Radiotherapy | Pediatrics | Usage | HEAD | PATIENTS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIATION DOSES | NECK | RADIOTHERAPY | RHABDOMYOSARCOMAS | CHEMOTHERAPY | CONNECTIVE TISSUE
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 355 - 360
Purpose To investigate the relationship between jaw function, patient and treatment variables, and radiation dosimetry of the mandibular muscles and joints in... 
Radiology | Hematology, Oncology and Palliative Medicine | Dosimetry | Pterygoid muscle | Pediatric sarcomas | Radiation | Jaw depression | TRISMUS | CANCER | IRRADIATION | ONCOLOGY | GROWTH | COMPLICATIONS | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Osteosarcoma - drug therapy | Pterygoid Muscles - physiopathology | Prospective Studies | Chordoma - radiotherapy | Humans | Sarcoma, Ewing - pathology | Child, Preschool | Rhabdomyosarcoma - pathology | Infant | Masseter Muscle - physiopathology | Osteosarcoma - radiotherapy | Bone Neoplasms - pathology | Chordoma - pathology | Masseter Muscle - radiation effects | Young Adult | Rhabdomyosarcoma - radiotherapy | Pterygoid Muscles - radiation effects | Temporomandibular Joint - radiation effects | Rhabdomyosarcoma - drug therapy | Chordoma - drug therapy | Bone Neoplasms - drug therapy | Child | Sarcoma - radiotherapy | Sarcoma, Ewing - surgery | Radiotherapy Dosage | Chordoma - surgery | Jaw Diseases - etiology | Head and Neck Neoplasms - drug therapy | Temporomandibular Joint - physiopathology | Radiation Injuries - complications | Tumor Burden | Bone Neoplasms - surgery | Sarcoma - drug therapy | Sarcoma - pathology | Head and Neck Neoplasms - pathology | Sarcoma, Ewing - drug therapy | Head and Neck Neoplasms - radiotherapy | Bone Neoplasms - radiotherapy | Jaw Diseases - physiopathology | Osteosarcoma - surgery | Models, Biological | Sarcoma - surgery | Adolescent | Rhabdomyosarcoma - surgery | Head and Neck Neoplasms - surgery | Osteosarcoma - pathology | Sarcoma, Ewing - radiotherapy | Children | Sarcoma | Radiotherapy | Nuclear radiation | Health aspects | SURGERY | HEAD | JAW | PATIENTS | BIOPSY | ADULTS | RADIATION DOSES | JOINTS | INTERACTIONS | CHEMOTHERAPY | CHILDREN | SARCOMAS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | ENDOXAN | NECK | DOSIMETRY | MUSCLES | HAZARDS
Journal Article
Medical Physics, ISSN 0094-2405, 02/2013, Volume 40, Issue 2, pp. 021709 - n/a
Journal Article